You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
The challenge is open to nearly anyone with a tangible, unique idea to improve cancer care Robert Herjavec, technology entrepreneur, star of ABC's Emmy Award-winning hit television show Shark Tank...
Employees also raised nearly $60K at Second Annual “One Astellas Spirit Run” LAS VEGAS – JUNE 19, 2017 – Approximately 1,000 Astellas employees attending the company’s National Sales...
NORTHBROOK, Ill., June 6, 2017 /PRNewswire/ -- Astellas today announced data from an exploratory analysis of the Phase I/II CHRYSALIS study, which demonstrated that FLT3 mutation-positive...
-Pivotal Monotherapy Phase 2 Trial Initiation Planned for 2017- CHICAGO, June 5, 2017 /PRNewswire/ -- Astellas and Seattle Genetics, Inc. (NASDAQ: SGEN) today highlighted updated phase 1 data for...
Follow U.S. news
